The global vaginitis treatment drug market is projected to grow steadily, expanding from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, at a compound annual growth rate (CAGR) of 4.8%. This growth is driven by increasing awareness of women’s health, rising prevalence of vaginitis, and heightened demand for effective treatments for bacterial …